WeedMD Stock Forecast, Price & News

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for WeedMD in the last year. There are currently 2 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" WeedMD stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in WMD, but not buy additional shares or sell existing shares.
View analyst ratings for WeedMD or view top-rated stocks.

Wall Street analysts have given WeedMD a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but WeedMD wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

WeedMD is scheduled to release its next quarterly earnings announcement on Wednesday, September 29th 2021.
View our earnings forecast for WeedMD.

WeedMD Inc. (CVE:WMD) posted its earnings results on Tuesday, June, 29th. The company reported ($0.03) earnings per share for the quarter. The firm earned $12.90 million during the quarter.
View WeedMD's earnings history.

WeedMD's stock was trading at C$0.38 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, WMD stock has decreased by 26.7% and is now trading at C$0.28.
View which stocks have been most impacted by COVID-19.

2 brokers have issued 1 year price objectives for WeedMD's shares. Their forecasts range from C$0.30 to C$0.60. On average, they expect WeedMD's share price to reach C$0.45 in the next year. This suggests a possible upside of 63.6% from the stock's current price.
View analysts' price targets for WeedMD or view top-rated stocks among Wall Street analysts.

Some companies that are related to WeedMD include The Supreme Cannabis (FIRE), Leaf Mobile (LEAF), ESSA Pharma (EPI), ICC Labs (ICC), Medexus Pharmaceuticals (MDP), Science in Sport (SIS), Diurnal Group (DNL), BioSyent (RX), The Green Organic Dutchman (TGOD), Shield Therapeutics (STX), Delta 9 Cannabis (NINE), Venture Life Group (VLG), Cipher Pharmaceuticals (CPH), Indiva (NDVA) and Acerus Pharmaceuticals (ASP).
View all of WMD's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other WeedMD investors own include (CGC), Aurora Cannabis (ACB), Canopy Growth (WEED), Aphria (APHA), Cara Therapeutics (CARA), Cronos Group (CRON), Tencent (TCEHY), Aduro Biotech (ADRO), Aurora Cannabis (ACB) and Auxly Cannabis Group (CBWTF).

WeedMD trades on the Canadian Venture Exchange (CVE) under the ticker symbol "WMD."

Shares of WMD and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

One share of WMD stock can currently be purchased for approximately C$0.28.

WeedMD has a market capitalization of C$67.82 million and generates C$27.53 million in revenue each year.

WeedMD employs 212 workers across the globe.

The official website for WeedMD is www.weedmd.com.

WeedMD is headquartered at 320 Bay St Suite 1600, TORONTO, ON M5H 4A6, Canada.

WeedMD's mailing address is 320 Bay St Suite 1600, TORONTO, ON M5H 4A6, Canada. The company can be reached via phone at +1-416-5153923.